224 related articles for article (PubMed ID: 27423480)
1. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
[TBL] [Abstract][Full Text] [Related]
3. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
[TBL] [Abstract][Full Text] [Related]
4. Structural studies of pterin-based inhibitors of dihydropteroate synthase.
Hevener KE; Yun MK; Qi J; Kerr ID; Babaoglu K; Hurdle JG; Balakrishna K; White SW; Lee RE
J Med Chem; 2010 Jan; 53(1):166-77. PubMed ID: 19899766
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design.
Babaoglu K; Qi J; Lee RE; White SW
Structure; 2004 Sep; 12(9):1705-17. PubMed ID: 15341734
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of novel pyrimido[4,5-c]pyridazine derivatives as dihydropteroate synthase inhibitors with increased affinity.
Zhao Y; Hammoudeh D; Yun MK; Qi J; White SW; Lee RE
ChemMedChem; 2012 May; 7(5):861-70. PubMed ID: 22416048
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, antibacterial evaluation and molecular docking studies of some new quinoxaline derivatives targeting dihyropteroate synthase enzyme.
El-Attar MAZ; Elbayaa RY; Shaaban OG; Habib NS; Abdel Wahab AE; Abdelwahab IA; El-Hawash SAM
Bioorg Chem; 2018 Feb; 76():437-448. PubMed ID: 29275262
[TBL] [Abstract][Full Text] [Related]
8. Catalysis and sulfa drug resistance in dihydropteroate synthase.
Yun MK; Wu Y; Li Z; Zhao Y; Waddell MB; Ferreira AM; Lee RE; Bashford D; White SW
Science; 2012 Mar; 335(6072):1110-4. PubMed ID: 22383850
[TBL] [Abstract][Full Text] [Related]
9. Dihydropteroate synthase from Streptococcus pneumoniae: structure, ligand recognition and mechanism of sulfonamide resistance.
Levy C; Minnis D; Derrick JP
Biochem J; 2008 Jun; 412(2):379-88. PubMed ID: 18321242
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of bi-substrate state mimics of dihydropteroate synthase as potential inhibitors and molecular probes.
Qi J; Virga KG; Das S; Zhao Y; Yun MK; White SW; Lee RE
Bioorg Med Chem; 2011 Feb; 19(3):1298-305. PubMed ID: 21216602
[TBL] [Abstract][Full Text] [Related]
11. Class-Specific Monoclonal Antibodies and Dihydropteroate Synthase in Bioassays Used for the Detection of Sulfonamides: Structural Insights into Recognition Diversity.
Li C; Liang X; Wen K; Li Y; Zhang X; Ma M; Yu X; Yu W; Shen J; Wang Z
Anal Chem; 2019 Feb; 91(3):2392-2400. PubMed ID: 30580515
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate.
Morgan RE; Batot GO; Dement JM; Rao VA; Eadsforth TC; Hunter WN
BMC Struct Biol; 2011 May; 11():21. PubMed ID: 21554707
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
Achari A; Somers DO; Champness JN; Bryant PK; Rosemond J; Stammers DK
Nat Struct Biol; 1997 Jun; 4(6):490-7. PubMed ID: 9187658
[TBL] [Abstract][Full Text] [Related]
14. Dapsone is not a Pharmacodynamic Lead Compound for its Aryl Derivatives.
Scior T; Abdallah HH; Salvador-Atonal K; Laufer S
Curr Comput Aided Drug Des; 2020; 16(3):327-339. PubMed ID: 32507104
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity, computational analysis and host toxicity study of thymol-sulfonamide conjugates.
Swain SS; Paidesetty SK; Padhy RN
Biomed Pharmacother; 2017 Apr; 88():181-193. PubMed ID: 28107695
[TBL] [Abstract][Full Text] [Related]
16. Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.
Zhao Y; Hammoudeh D; Lin W; Das S; Yun MK; Li Z; Griffith E; Chen T; White SW; Lee RE
Bioconjug Chem; 2011 Oct; 22(10):2110-7. PubMed ID: 21916405
[TBL] [Abstract][Full Text] [Related]
17. New acrylamide-sulfisoxazole conjugates as dihydropteroate synthase inhibitors.
Nasr T; Bondock S; Ibrahim TM; Fayad W; Ibrahim AB; AbdelAziz NA; Sakr TM
Bioorg Med Chem; 2020 May; 28(9):115444. PubMed ID: 32220521
[TBL] [Abstract][Full Text] [Related]
18. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.
Valderas MW; Andi B; Barrow WW; Cook PF
Biochim Biophys Acta; 2008 May; 1780(5):848-53. PubMed ID: 18342015
[TBL] [Abstract][Full Text] [Related]
19. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
Vinnicombe HG; Derrick JP
Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of new Schiff bases of sulfamethoxazole and sulfathiazole, their antibacterial activity and docking computation with DHPS protein structure.
Mondal S; Mandal SM; Mondal TK; Sinha C
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():268-79. PubMed ID: 26056977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
